Reimagining the research-practice relationship: policy recommendations for informatics-enabled evidence-generation across the US health system by Embi, Peter J. et al.
Perspective
Reimagining the research-practice relationship: policy
recommendations for informatics-enabled evidence-
generation across the US health system
Peter J. Embi1, Rachel Richesson2, Jessica Tenenbaum3, Joseph Kannry4, Charles
Friedman5, Indra Neil Sarkar6 and Jeff Smith7; The members of 2016 AMIA Policy
Invitational Planning Committee
1Regenstrief Institute, 1101 West 10th Street, Indianapolis, Indiana 46202, USA, 2Duke University School of Nursing, 307 Trent
Drive, Durham, North Carolina 27710, USA, 3Duke University School of Medicine, 2424 Erwin Road, Durham, North Carolina 27705,
USA, 4Icahn School of Medicine at Mount Sinai, Box 187, New York, New York 10029, USA, 5Department of Learning Health Sci-
ences, University Michigan Medical School, 1111 E. Catherine, St. Ann Arbor, Michigan 48109-2054, USA, 6Center for Biomedical
Informatics, Brown University, Box G-R, Providence, Rhode Island 02912, USA and 7American Medical Informatics Association,
4720 Montgomery Ln., Suite 500, Bethesda, Maryland 20814, USA
Corresponding Author: Peter J. Embi, MD, MS, Regenstrief Institute, 1101 West 10th Street, Indianapolis, IN 46202, USA
(pembi@regenstrief.org)
Received 30 March 2018; Revised 16 October 2018; Editorial Decision 6 November 2018; Accepted 21 November 2018
ABSTRACT
The widespread adoption and use of electronic health records and their use to enable learning health systems
(LHS) holds great promise to accelerate both evidence-generating medicine (EGM) and evidence-based medi-
cine (EBM), thereby enabling a LHS. In 2016, AMIA convened its 10th annual Policy Invitational to discuss issues
key to facilitating the EGM-EBM paradigm at points-of-care (nodes), across organizations (networks), and to en-
sure viability of this model at scale (sustainability). In this article, we synthesize discussions from the conference
and supplements those deliberations with relevant context to inform ongoing policy development. Specifically,
we explore and suggest public policies needed to facilitate EGM-EBM activities on a national scale, particularly
those policies that can enable and improve clinical and health services research at the point-of-care, accelerate
biomedical discovery, and facilitate translation of findings to improve the health of individuals and populations.
Key words: research informatics, clinical informatics, learning health systems, evidence-generating medicine, evidence-based
medicine, policy
INTRODUCTION AND BACKGROUND
As a consequence of the almost universal adoption of electronic
health records (EHRs) in the United States (US), “data-driven”
healthcare—long considered merely theoretical—is now within
reach and holds great promise.1 However, despite the unprecedented
volumes of clinical data generated each day across hospitals, physi-
cian offices, urgent care facilities, and neighborhood walk-in clinics,
the ability to leverage these data to increase our knowledge of health
and disease and drive improvements in care remain overwhelmingly
unrealized.2
The evidence-based medicine (EBM) paradigm has become the
bedrock paradigm of clinical decision-making over the last two dec-
ades. Today, EBM is being facilitated via the use of EHRs, and its
corollary—“evidence-generating medicine” (EGM)—can be opera-
tionalized in order to enable the generation of evidence from real-
world practice. This approach has the potential to transform a
severely limited clinical research system, one that is expensive,
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inefficient, and incapable of scaling to address the myriad unan-
swered clinical questions faced by clinicians and patients.3,4 EGM is
the “systematic incorporation of research and quality improvement
considerations into the organization and practice of healthcare in or-
der to advance biomedical science and thereby improve the health of
individuals and populations.”5 The EGM paradigm recognizes that
clinical care activities are not entirely distinct from research activities
and that the generation of evidence is critical to the EBM lifecycle.6
EGM is therefore an important and necessary element of enabling a
learning health system (LHS), one that seeks to systematically learn
from each healthcare encounter, facilitate discovery, and advance our
collective understanding of effective approaches to healthcare.7
Increasingly, all health stakeholders have the opportunity—and
obligation—to leverage health information technology (IT) systems,
and the valuable data they contain, for the development and delivery
of new interventions. The success of several current high-impact,
high-visibility research initiatives depend on actualizing this evi-
dence cycle. Examples include the All of Us Research Program8 and
Cancer Moonshot initiative,9 the Health Care Systems Research
Collaboratory,10 and the development of a national system of real-
world evidence generation system as pursued by such groups as the
US Food & Drug Administration (FDA), Patient-Centered Out-
comes Research Institute (PCORI), National Institutes of Health
(NIH), and other federal agencies.11
It was with this environment and motivation in mind that for 2
days in September 2016, AMIA convened its 10th annual AMIA Pol-
icy Invitational (API2016) meeting that brought together key thought
leaders to discuss informatics issues related to realizing the emerging
paradigm of an EBM-EGM cycle to enable the LHS. As further de-
scribed below, through a series of facilitated group discussions before
and during the API, a strategy for realizing the vision of nationally
scaled EGM was developed. The emergent framework focused on fa-
cilitating: (1) research opportunities at the “point-care” (nodes), (2)
research conducted across organizations (networks), and (3) ensuring
the ongoing viability of research at regional/national levels (sustain-
ability). This article explores those discussions and findings in more
detail and suggests a range of public policies needed to facilitate
EGM activities on a national scale. Special attention in paid to those
policies that can enable and improve clinical research at the point-of-
care, accelerate biomedical discovery, and enable translation of find-
ings to improve the health of individuals and populations. Below, we
synthesize discussion from the meeting and supplement those conver-
sations with relevant context to inform ongoing policy development.
MEETING STRUCTURE
The 2016 AMIA Policy Invitational (API2016) included over 70 par-
ticipants that were invited based upon experience and research con-
tributions focused at the intersection of care delivery and research.
Approximately 80% were AMIA members, with the remaining 20%
composed of policy professionals and non-AMIA members from in-
dustry, government, professional associations. Attendees were iden-
tified by the conference chair and were not paid for their
participation. Based upon premeeting deliberations led by a core
group of experts that constituted the API2016 planning committee,
the 2-day meeting was segmented into three broad levels of abstrac-
tion: (1) nodes, (2) networks, and (3) sustainability. Each level was
covered in a portion of the meeting that included expert presenta-
tions on key topics followed by breakout working group discussions
to further explore the topic and its policy implications. The first
session focused on how to integrate research at the point-of-care,
symbolized as a node. Next, meeting attendees considered issues
and policy implications related to conducting research that spanned
multiple healthcare and research organizations, or networks.
Finally, attendees considered public policy issues that would con-
tribute to the long-term sustainability of such a national research-
practice ecosystem. (See Table 1 for questions presented to API2016
participants.) In preparation for the API2016, AMIA staff deployed
a website12 that supported preconference collaboration and discus-
sion. Breakout session questions were posted 2 weeks in advance of
the meeting, and participants were encouraged to engage with fel-
low attendees by considering the questions via discussion threads.
To supplement these discussions, API2016 attendees also heard
keynotes given by National Library of Medicine Director Dr. Patri-
cia Brennan, FDA Commissioner Dr. Robert Califf, and Agency for
Healthcare Research and Quality Director Dr. Andrew Bindman. A
summary of their remarks and links to their presentations can be
found in Table 2.
FINDINGS AND RECOMMENDATIONS
Key findings and recommendations from the meeting participants
were captured, reviewed, categorized, and cataloged by the authors
using an iterative, qualitative analytic approach that led to group
consensus. The findings are summarized below. Recommendations
for each set of findings are further detailed in Table 3.
Nodes: policies needed to facilitate evidence generation
at the local level
Finding: clinicians, patients, and health systems are not routinely
engaged in research and often treat it as a separate component from
care delivery. Focusing on enabling evidence-generation activities at
the point-of-care as the most basic locus of research is vital because
it represents a single, yet connected, node in a complex and inte-
grated network
Policy implication: incentives are needed for key stakeholders to pri-
oritize research at the point-of-care—the nodes of an EGM system.
Participating in certain research-related activities at the point-of-
care can involve an opportunity cost to clinicians and healthcare
Table 1. Breakout discussion questions
Breakout A: Nodes: Evidence Generation at the Local Level
1. What policies can better engage clinicians, patients and health sys-
tems in research activities?
2. How do current policies, such as the Health Insurance Portability
and Accountability Act (HIPAA) and Common Rule, present bar-
riers to EGM and clinical research?
3. Which policies can ensure EHRs include functions developed to fa-
cilitate research? (eg recruitment, incorporation of results back to
front-line clinicians.)
Breakout B: Networks: Clinical Research Across Organizations
1. What policies inhibit multisite research and how might they be
addressed?
2. What policies can improve information flows to support reproduc-
ibility, quality, veracity, and completeness of data?
3. What are the technical barriers to sharing data within and across net-
works? How can public policy address these barriers?
Breakout C: Sustainability: Maintaining a National Research Ecosystem
1. What policies are needed to address the long-term challenges (related
to payment or funding of research) of maintaining a selfsustaining
research ecosystem?
2. What policies and policy-making mechanisms are needed sustain
and promote innovation within a national research ecosystem?
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systems that must be recognized and addressed to align incentives
for enabling research and care nodes. Actions by Congress and the
Executive Branch over the past decade have helped improve the en-
gagement of patients and clinicians in research. Through research
programs led by PCORI and federal research funding agencies, pa-
tient participation in research design and policy development has
been explicitly required.13–16 Further, these agencies have made
strides in having patients and clinicians work together to fund, de-
sign, and implement research studies that address real-world ques-
tions that are important to patients.17 However, to be effective, this
trend must continue with the current Administration and Congress;
steps should be taken to replicate this kind of engagement with both
clinicians and health systems. Specifically, CMS should leverage its
Quality Payment Program to reward clinical practice Improvement
Activities (IAs) that involve research components. This would en-
courage office-based physicians to invest time and resources needed
to realize EGM. Further, federal agencies should develop funding
priorities and special emphasis notices that encourage clinicians and
health systems to collaborate in research studies and commit to
share study results, in both raw data and curated formats, back to
clinicians and patients. Practice-Based Research Networks (PBRNs)
also remain a promising model for primary care clinicians and prac-
tices working together to answer community-based health questions
and to translate those findings into practice.18
Finding: current regulations present real and perceived barriers to
evidence generation at the local level
Policy implication: regulatory modifications are needed to facilitate
research at the point-of-care. There is wide disparity in how current
regulations governing informed consent and privacy protections are
Table 2. Summary of presentations
Title/Speaker Key findings
Keynotes The role of the NLM in Reimagining the
Research-Practice Relationship in the
Post-Meaningful Use Era
1. Knowledge resources and representational standards can support research at the
point of clinical care, by enabling activities such as identifying clinical trials rele-
vant to individual patients, screening or referral of patients to trials, and collect-
ing research data. Results reporting via ClinicalTrials.gov is foundational for
enabling outside stakeholders to benefit from research.
2. Failure to report research results to ClinicalTrials.gov is a systemic problem that
stifles national scientific advances because: (1) not all trials are published; (2) not
all outcome measures (or adverse events) are published; and (3) changes to proto-
cols are not always specified.
3. A final rule published in September 2016 will enable better enforcement of
requirements for depositing clinical trial information on ClinicalTrials.gov. This
will enable potential participants to find relevant studies, facilitate tracking of
protocol changes, and increase the transparency and tracking of studies / outcome
measures for EBM, ultimately supporting efficient allocation of resources.
Patricia Flatley Brennan, RN, PhD, Director,
United States National Library of Medicine
Generating Evidence to Inform Decisions in the
Era of Precision Medicine
1. One big challenge in biomedicine is that we are missing the ability to measure the
interactions of biology, sociology, environment, and organizational factors that
could enable the individualization and optimization of care and improve popula-
tion health. Although health and disease result from interactions of genes, deriva-
tive biological systems, environment, social context, and personal decisions,
researchers often examine only one of these aspects. We are not collecting or ana-
lyzing the range of data needed to generate evidence needed to inform the health
decisions that patients and their doctors make every day.
2. We must organize systems that can embed research into clinical practice. Com-
mon approaches for configuring, storing and reusing digital health data can en-
able the widespread participation in research required to generate the high-
quality evidence that is badly needed for therapeutic research, safety surveillance,
public health, and quality improvement.
3. We need to train the workforce of the future provide and curate data using stand-
ards and terminology that support research and clinical care, collected by systems
and interfaces that allow clinicians to spend more time with patients.
Robert Califf, MD, Commissioner, Food and
Drug Administration
Building a Research Strategy to Support Learn-
ing Health Systems
1. Our health care system lags in its ability to adapt, affordably address patient
needs, and consistently achieve better outcomes. We have the know-how and
technology to substantially improve quality and reduce costs, but need to develop
strategies that can be applied in dynamic and complex systems.
2. Health IT supports acquisition of data to provide measurement in real time, and
find and analyze trends far faster than humans; and get needed information to
clinicians at the point of care, when and where they need it. When systems are in
place and incentives are aligned, IT can create a continuous feedback loop so
that we are always learning—and that is the foundation of a learning health care
system.
3. Practice-Based Research Networks (PBRNs) are ideal settings for studying
the process of care and the manner in which diseases are diagnosed, treatments
initiated, and chronic conditions managed in real-world settings. PBRNs provide
opportunities to measure effectiveness and explore the interface between patients
and their primary physicians.
Andy Bindman, MD, Director, Agency for
Healthcare Research and Quality
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Table 3. Summary findings and recommendations
Topic Findings Recommendations
Nodes: Evidence Generation
at the Local Level
Clinicians, patients and health systems are
not routinely engaged in research and of-
ten treat it as a separate component from
care delivery. As it represents a single
node in what should be a complex and in-
tegrated network, focusing on a single
point of care as the most basic locus of re-
search is vital.
1. Incentives are needed for key stakeholders to prioritize research at
the point-of-care
A. Federal policies should incentivize health systems and clinicians to
engage in research activities through reimbursement policies, fund-
ing announcements, and other organizational incentives.
B. Federal policies should reward patients, clinician, and health sys-
tem participation in research with access to raw and curated
results and enable them to contribute to research design.
C. Review and potentially reinvigorate Practice-Based Research Net-
works.
Current regulations present real and per-
ceived barriers to evidence generation at
the local level.
2. Regulatory modifications are needed to facilitate research at the
point-of-care
A. The administration must faithfully implement 2018 Revisions to
the Common Rule as well as establish the 21st Century Cures-
mandated Research Policy Board. The administration must imple-
ment this provision to better calibrate and harmonize our sprawl-
ing and incoherent federal research regulations.
B. The Precision Medicine Initiative Privacy and Trust Principles
should serve as a framework for local, regional and national-level
privacy and confidentiality laws/regulations. Current laws and reg-
ulations should be modified to be consistent with these Principles.
C. These recommendations notwithstanding, federal officials should
develop comprehensive guidance, education, and specific examples
of the kinds of research beyond the purview of the Common Rule.
Technical work on data standards and certi-
fied health IT functionality is needed to
enable EGM and local learning health sys-
tems.
3. Investment in the “basic science” of health IT is necessary
A. The HHS Office of Civil Rights (OCR) should refine the definition
of a HIPAA Designated Record Set (DRS) and ONC should ex-
plore ways to allow patients to have a full digital export of their
structured and unstructured data within a Covered Entity’s DRS in
order to share their data for research.
B. In order to facilitate data reuse and interoperability, regulators
should work with stakeholders to develop granular data specifica-
tions, including metadata, and standards to support research for
use in the federal health IT certification program.
C. Research organizations and the professional societies that sup-
port researchers should develop functional and technical require-
ments of EHRs and other health IT modules to facilitate research
at the point of care and EGM.
Networks: Clinical Research
Across Organizations
The clinical and research workforce, includ-
ing Institutional Review Board (IRB) staff,
data stewards and data curators often
lack a fundamental understanding of in-
formatics-driven research methodologies.
1. Informatics-driven research requires a skilled workforce and federal
support for informatics training
A. Informatics training programs at the NLM, AHRQ, and other
agencies should be expanded, and clinical informatics fellowships
made possible through CMS funding of GME training should be
increased.50
B. The certifying body to IRBs should require minimum levels of in-
formatics competencies are represented within all IRBs and grant
review panels.
Incompatible data standards—including
metadata and patient identifiers—and
data use agreements create technical chal-
lenges and tremendous administrative
burden on multisite research.
2. Convergence of technical standards and governance can facilitate
multisite research and reduce legal burden
A. Federal agencies should encourage development of data stand-
ards at the intersection of care delivery and research, including
voluntary patient identifiers, and advocate for their adoption in
all organizations that aspire to be LHS.
B. The NIH Health Care Systems Research Collaboratory should
continue as a project of special focus to improve the conduct and
utility of pragmatic clinical trials. Collaboratory activities to-date
should be evaluated and funding should support positive aspects
of the evaluation.
C. Funding agencies should convene awardee stakeholders to de-
velop a series of standardized data use agreements to be used for
different categories of clinical research and these standardized
data use agreements should be compulsory as a condition of
funding.
(continued)
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applied across healthcare delivery settings, often resulting in an envi-
ronment where research is stymied. As part of the January 19, 2017
final rule revising the Common Rule,19 the Office of Human Research
Protections (OHRP) created a new exemption meant to relieve
researchers from Common Rule compliance if they are already regu-
lated by HIPAA. This is a positive development for EGM, and we en-
courage OHRP to produce educational materials and guidance to
help ensure that such research-facilitating provisions are uniformly
understood and implemented across care delivery settings when the
compliance date arrives in January 2019. In addition, HHS should
promote recent guidance from the Office of Civil Rights (OCR) re-
garding individual authorization for uses and disclosures of protected
health information for research.20 Last, the administration’s Office of
Management and Budget (OMB) was tasked with establishing a Re-
search Policy Board within 1 year of enactment of 21st Century Cures
to make recommendations regarding the modification and harmoni-
zation of research regulations and policies.21 More than a year and
half since 21st Century Cures became law, the Research Policy Board
has not been established. The administration must implement this sec-
tion of legislation to better calibrate and harmonize our sprawling
and incoherent federal research regulations.
Finding: technical work on data standards and certified health IT
functionality is needed to enable EGM and local learning health
systems
Policy implication: investment in the “basic science” of health IT, in-
cluding supporting standards and processes for implementing and
enhancing functional requirements, is necessary. Data standards are
necessary to the exchange of clinical data and interoperability be-
tween EHR systems will be critical for data aggregation and sharing.
The development, harmonization, and use of standards for vocabu-
lary, format, and transport will be essential for the continued im-
provement of health IT tools necessary to support EGM and LHS.
While interoperability is an on-going challenge, agreement on stand-
ards is foundational to realizing the potential benefits of IT. As tools
for care delivery, EHRs are not readily configured to facilitate EGM
or supplemental uses of patient data for research, even when a pa-
tient explicitly wants to enable that use. IT tools that support the
screening and recruitment of patients into research in the context of
a healthcare encounter are needed, as are tools that enable patients
to easily access their health data and transfer it to (share it with) re-
search activities and investigations as they wish.
Networks: clinical research across organizations
The development of processes and systems to generate evidence at
points-of-care (nodes) is an essential component of a LHS.22–24 The
value of research conducted at organizational nodes can be magni-
fied when the nodes are integrated into networks. Networks of
organizations, working in tandem, can leverage efficiencies of scale
to include more clinicians and more patients in the generation of im-
portant knowledge, thereby mitigating common research challenges
related to sufficient sample size, “representativeness” of sample pop-
ulations, and the “generalizability” of study results.
Research networks are of two types—regional (typically less
than 5 organizations, often privately funded and geographically or-
ganized) and national-scale networks, which include a larger num-
ber of organizations, wider geographical distribution, and often rely
on federal or foundation funding for large centralized infrastructure.
Table 3.. continued
Topic Findings Recommendations
Sustainability: Maintaining a
National Research
Ecosystem
The effectiveness of our national research
networks is dependent on shared infra-
structure that require appropriate levels of
government support to complement initia-
tives from the private sector.
1. Federal funders should see an increasing proportion of their research
portfolios as strategic investments rather than time-limited projects
and coordinate them as such.
A. In order for the US to maintain its position as a leader in biomedi-
cal research, it must continue to prioritize large-scale cyberinfras-
tructure through dedicated funding.
B. Federal investments in this infrastructure should take a long-term
view, analogous to the concept of the National Science Founda-
tion’s Supercomputing Program, rather than a project-based
view.
The benefits of federally sponsored research
must extend as much as possible beyond
the awardees who conduct the research.
2. Federal policy must improve the use of research data and the appli-
cation of new knowledge for multiple stakeholders to derive value.
A. Grants that require Data Sharing Plans should treat them as a
“scorable” element of the application and informatics professio-
nals should be part of the review process.
B. Funds should encourage multiagency collaboration on research
and require translational phases earlier in the award cycle. The
NCATS and the CTSA Program should be viewed as a potential
coordinator of such projects.
C. A portion of funds must be dedicated towards implementation of
research findings, including with CMS, VA, and the DoD.
D. Federal research funders should promote projects that leverage
health informatics tools that enable patients to:
a. Participate in research as part of their healthcare experience,
b. Actively share their own health data with researchers of their
choosing, and
c. Obtain the return of results of research in which they participate.
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(These national networks are described in Sustainability: maintain-
ing a national research ecosystem section.) To identify the factors
that enable regional and national research networks, API2016 par-
ticipants organized into smaller breakout groups with targeted dis-
cussion on policy issues surrounding multisite research. Specifically,
these groups discussed information flows to improve reproducibil-
ity, quality, veracity and completeness of data, and barriers to data
sharing. A number of common themes emerged, falling into the fa-
miliar categories of people, process, and technology. Later, the
breakout groups reconvened into the larger API2016 group to de-
velop consensus findings on the major challenges for networked re-
search, which are presented below.
Finding: the clinical and research workforce, including institutional
review board (IRB) staff, data stewards, and data curators often
lack a fundamental understanding of informatics-driven research
methodologies
Policy implication: informatics-driven research requires improved
workforce competencies and federal support for informatics train-
ing. The healthcare and research enterprise envisioned for the 21st
century will require a workforce competence beyond the mechanics
of health IT and health information management.7,24 The API2016
participants identified three kinds of education and training that are
necessary to EGM and the LHS: (1) basic “informatics literacy” for
all health professionals incorporated with health practitioner educa-
tion,25–27 biomedical research training,28 and public health educa-
tion29; (2) intensive applied informatics training for an additional
cohort of practitioners to improve leadership and expertise in apply-
ing informatics principles to healthcare problems30,31; and (3) Sup-
port for informatics education professionals who will advance the
science and train the next generation of informatics professionals.32–
34 “Informatics literacy” includes awareness of specific data stand-
ards and their importance to multisite research, the mechanics of
data sharing, and the fulfillment of user needs that are specific to
EBM, EGM, and learning cycles. Informatics professionals should
be represented across all IRBs and grant selection committees where
data sharing and informatics tools are part of the research.
Finally, a competent workforce for the future will depend upon fed-
erally funded recruitment and educational programs—targeted to high
school, undergraduate, and professional students—that will encourage
the next generation of health practitioners and researchers to engage in
the science and practice of informatics.35 This includes continuation of
federal support for programs at the National Library of Medicine,36 the
Agency for Healthcare Research and Quality,37 and Clinical Informatics
Fellows funded through Graduate Medical Education.38
Finding: incompatible data standards—including metadata and
patient identifiers—and data use agreements create technical
challenges and tremendous administrative burden on multisite
research
Policy implication: convergence of technical standards and gover-
nance can facilitate multi-site research and reduce legal burden.
Organizations should be able to “consume” research findings from
other organizations and networks (as part of their LHS mission) and
share results with the broader community as EGM. This requires
technical standards for data representation and exchange.39–41 Re-
gardless of whether they are in regional ad hoc research networks or
part of nationally recognized research networks, health delivery
organizations should be able to participate in multisite research, col-
laboration, and knowledge sharing. The development of a trusted
exchange framework and common agreement, as required by the
21st Century Cures Act,42 is meant to ease legal burdens to ex-
change clinical data for providers in treating patients. A similar
mechanism should be spearheaded to help private-sector stakehold-
ers share clinical data for research purposes, especially for small
institutions that wish to contribute to research and participate in
EGM, but are not part of PCORnet,43 CTSA44 or other national re-
search networks. Such trust and collaboration frameworks can be
informed by the experience of the NIH Health Care Systems Re-
search Collaboratory, one part of the overall effort to improve the
national capacity to generate evidence that informs healthcare deci-
sions by patients, providers, and payers.45,46 Indeed, via a series of
demonstration projects using a pragmatic research approach, Col-
laboratory investigators have shared lessons learned regarding the
design, execution, and dissemination research conducted in partner-
ship with multiple healthcare systems.47 Among other recommenda-
tions, the Collaboratory EHR Core advocates for more federally
driven (data) standards (to reduce the complexity and transforma-
tions required for multisite research) and policies to ensure that fu-
ture electronic health record systems have the flexibility to support
research, including implementation of new standardized data collec-
tion that fits into clinical workflows.45,46
Sustainability: maintaining a national research
ecosystem
Finding: the effectiveness of our national research networks will be
dependent upon shared infrastructure requiring adequate support
from the private sector and federal agencies
Policy implication: federal funders should see an increasing propor-
tion of their research portfolios as strategic investments rather than
time-limited projects and coordinate them as such. Large scale infra-
structure, supported by federal funding, is essential to the continued
dominance of US biomedical research. This infrastructure includes
both technology and the policies and procedures that enable best use
of the technology. Federal investments in this infrastructure should
take a long-term view, analogous to the concept of the National Sci-
ence Foundation’s Supercomputing Program,48 rather than a
project-based view, which places predetermined end points on fede-
ral support. Use of more agile funding mechanisms such Other
Transaction Authority, and Cooperative Agreements, can help these
programs work at the cutting edge of technology and be responsive
to future needs in a rapidly changing environment.
Finding: the benefits of federally sponsored research must extend as
much as possible beyond the awardees who conduct the research
Policy implication: federal policy must improve the use of research
data and the application of new knowledge for multiple stakehold-
ers to derive value. Policies should target the reuse of data through
improved data sharing plans and harmonized data management/
sharing policies across NIH institutions and centers. Similar policies
could target reusability of biomedical knowledge that results from
research studies, so this knowledge can be more readily applied to
the improvement of health and care. Trans-NIH collaboration, as
well as collaboration among other funding agencies, should com-
pose a minimal percentage of the federal biomedical research portfo-
lio so that research results can be more readily translated into
practice. This concept should extend to the CMS, Veterans Health
Administration and Defense Health Services, so that national-level
research findings can be implemented at scale, as appropriate.
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Finally, patients and families should be recognized as key stake-
holders in our national research ecosystem, and they should be lever-
aged to enhance health IT systems for research, promote data
standards, and help develop organizational research participation
policies.49 Patients and the public will ultimately be the beneficiaries
of research, and they can promote the value of research through par-
ticipation and driving research questions. Federal research funders
should promote projects that leverage health informatics tools that
enable patients and their families to participate in research as part of
their healthcare experience whatever their geographical location, ac-
tively share their own health data with researchers of their choosing,
and obtain the return of results of research in which they
participate.
CONCLUSION
The AMIA 2016 Policy Invitational brought together informatics
experts from across the spectrum of care and research with national
policy leaders for a structured dialog designed to address barriers to
EGM within the context of regional and national-level research and
participants identified a number of possible solutions that could be
supported by policy and advocacy. The findings of API2016 confirm
that strategic co-ordination and co-operation on a national scale
will be required in order to achieve safe and effective patient care
amid continuous advances in medical knowledge and proliferation
of HIT tools. As a multidisciplinary, multistakeholder organization
representing more than 5400 members, AMIA appreciates the need
for synergy between people, technology, and systems. Innovation
and impact in care delivery and clinical research will depend on pub-
lic policies that encourage collaboration, co-operation, and shared
digital infrastructure.
In order to achieve the vision of nationally scaled evidence-
generating medicine where individual nodes contribute to larger net-
works and—ultimately—a sustainable LHS, national leadership,
and investment is needed. Continued and increased funding for ad-
vanced health informatics training and cyberinfrastructure will be
essential to ensure that biomedical research and EGM can be used
to improve population health and healthcare delivery in the US.
Without federal support to train clinicians and researchers on the
fundamentals of health informatics literacy, we will fail to overcome
current challenges and discover answers to important questions that
face clinicians and patients. Further, without the cyberinfrastructure
necessary to ask and answer clinical questions across disparate re-
search networks, based on the best evidence-based knowledge and
growing real-world data, we will not realize our vision of a LHS.
The National Science Foundation has initiated important research in
this area and NCATS has continued to fund large-scale projects.
Moving forward, other agencies (eg AHRQ, ONC, CMS, CDC, and
the VA) that would benefit from the promulgation of EGM should
consider collaborative approaches to support the infrastructure re-
quired to generate evidence and implement findings more routinely
and quickly.
Second, national policies should enable organizations to con-
sume research findings from other organizations and networks eas-
ily, and share results with the broader community of healthcare and
research practitioners. The development of trust frameworks, as re-
quired by the 21st Century Cures Act, is meant to ease legal burdens
to exchange clinical data for providers in treating patients, so similar
mechanisms should be spearheaded to help private-sector stakehold-
ers share clinical data for research purposes, especially for small
institutions who wish to contribute to research, but are not part of
PCORnet, the CTSA program, or other national research networks.
The NIH Collaboratory is vital resource for development of such
processes and policies, and it should garner continued support from
Congress and the White House. Additionally, revisions made to the
Common Rule must be implemented in a co-ordinated fashion with
the private sector, so that the benefits of these new changes can be
realized across the country in consistent ways.
Finally, federal support is needed to ensure that better standards
are developed and adopted in the private sector. Data standards are
necessary to the exchange of clinical data and interoperability be-
tween health IT systems, are critical for data aggregation and shar-
ing in research. The development, harmonization, and use of
standards for vocabulary, format, and transport will be essential for
the continued improvement of health IT tools necessary to support
EGM and LHS. While interoperability is an on-going challenge,
agreement on standards is foundational to realizing the potential of
IT, and the federal government has important levers in certification
and payment policies to help align private-sector adoption and use
of health IT. The above recommendations will require the coopera-
tion and engagement of many disciplines and stakeholders, but the
return will have an impact on the costs of healthcare and biomedical
research. Optimizing the use of health IT to support health care and
research will create the infrastructure for LHS that ultimately can
improve the lives of all Americans, now and into the future.
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